3Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail, 2007,9 ( 5 ) :518-524.
4Leyva F, Anker SD, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J,1997,18(5):858-865.
8Sakai H,Tsutamoto T,Tsutsui T,et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circulation, 2006,70 ( 8 ) : 1006-1011.
9Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure:a marker of chronic inflammation. Eur Heart J, 1998,19 (12) : 1814-1822.
10Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med,1951,34(6) :1421-1431.
8Michael W, Christin H. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart,2006,92 (6) :843-849.
9Williams SG,Ng LL, Obrien R J, et al. Complementary roles of simple variable, NYHA and N-BNP,in indicating aerobic capacity and severity of heart failure. Int J Cardiol,2005,102 ( 2 ) :279-286.
10Kuster GM,Tanner H, Printzen G, et al. B-type natriuretic Peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly, 2002,132(43-44) :623-628.
